Business

BioMarin Pharmaceutical drug succeeds in clinical trial

Advertisement

BioMarin Pharmaceutical Inc. said an experimental treatment for Morquio A Syndrome, a rare genetic disease, succeeded in a clinical trial. The disease causes systemic skeletal dysplasia, short stature, and joint abnormalities, which limit mobility and endurance.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.